D
Drug Farm
Biotech & Life Sciences · Huangpu, China · Founded 2015
First-in-class therapies for metabolic and immunological diseases, discovered through proprietary AI and genetic screening platforms MoreLess
Drug Farm emerged as a mysterious player in the pharmaceutical landscape, with little public information about its origins or founders. Despite the lack of transparency, the company has managed to capture attention in the industry.
The company's journey is marked by its innovative approach to drug development, focusing on niche markets that larger pharmaceutical companies often overlook. This strategy has allowed Drug Farm to carve out a unique space for itself, though details about its operations remain scarce.
While there is no public record of significant events such as acquisitions, IPOs, or major funding rounds, Drug Farm's continued presence suggests a steady, if enigmatic, growth trajectory. The company's ability to maintain operations without the typical fanfare of public announcements or financial disclosures adds to its mystique.
In an industry where transparency is often key to building trust, Drug Farm's secretive nature sets it apart. Whether this approach will lead to long-term success remains to be seen, but for now, Drug Farm continues to intrigue industry watchers and competitors alike.
Company overview
Drug Farm company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2015
- Headquarters
- Huangpu, China
- Employees
- 99
- Open positions
- None listed
- Dealroom signal
- 69.2
Valuation & funding
Drug Farm funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | May 2023 | $27M | $280M | Detong Capital · Betta Capital · Wedo Venture Management · YD Capital | ↗ |
| SERIES AOther financing | Feb 2021 | $56M | $224M | WuXi AppTec · Zhejiang United Investment Holdings Group · Detong Capital · BVCF | — |
| SPINOUTOther financing | Jan 2015 | $0 | — | Fudan University · Yale University | — |
Growth signals
Drug Farm website traffic
Latest recorded traffic for Drug Farm is 1.6K monthly website visits, up 207.7% over the last three months. Drug Farm's team grew 0% over the past year.
Comparisons
Drug Farm compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Drug Farm's talent
Source: Dealroom Talent Intelligence.
Investors
11 investors on Drug Farm's cap table
Sourced from Dealroom's funding and investor records.






Global footprint
Where Drug Farm has talent and traffic
team presence
In the news
Latest news about Drug Farm
Recent press, funding announcements, and product moves mentioning Drug Farm — open to read from the original sources.
Market sentiment
What the market is saying about Drug Farm
An AI-synthesized read of the highest-engagement posts about Drug Farm on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Drug Farm’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







